IL6 and COVID-19: Summarized by Iba et al., circulating IL-6 level in COVID-19 patients was comparably high to that in other diseases exhibiting cytokine storms, including cytokine release syndrome after chimeric antigen receptor T cell therapy and hemophagocytic lymphohistiocytosis [120].